BDP1 and ovarian serous adenocarcinoma: We analyzed BDP1 expression in response to common serous ovarian cancer chemotherapies and at twelve‐month relapse‐free survival in patients treated with platin (Figure 5A), BDP1 expression significantly decreased (p = 3.2 × 10−05).